17 
tions located throughout the United States. S. 1217 cites that the 50 
inspectors be compensated at the annual rate of pay for GS-11 of the 
Federal Employee General Schedule or approximately $20,000 for 
fiscal year 1978. An additional 10 percent has been added to this figure 
to cover employee benefits. Administrative expenses were also com- 
puted to be 60 percent of the total salaries. The CBO Federal pay de- 
flator was applied to determine outyear costs. 
Part time ( fee for service) contract , individual consultant and technical 
advisory committee' 8 costs 
Fiscal year : Millions 
1978 $ 1. 0 
1979 — . 75 
1980 . 75 
1981 . 75 
1982 . 75 
The magnitude of individual consultant hours, contractual agree- 
ments and technical advisory committees’ time and services is not in- 
dicated in S. 1217. Thus, projected costs were based upon the experience 
of the National Commission for the Protection of Human Subjects 
in Clinical Research which is similar in composition and function. 
After the first year, in which guidelines are set and personnel are 
trained, continued periodic consultation services will be needed ; thus 
it is estimated that although outlays in the first year will be greater, 
there will be costs associated with the technical advisory committees 
in subsequent years. 
Penalties . — It is estimated that during fiscal year 1978 few or no 
penalties will be incurred. However, after more laboratories are opened 
and monitoring begins, violations with civil penalties may occur, but 
it is impossible to determine the magnitude of this at present. 
Employee protection . — The Occupational Safety and Health 
Agency of the Department of Labor estimates that while investigatory 
costs must be assumed by the National Recombinant DNA Safety 
Regulatory Commission in the course of an employee-complaintant’s 
action, these costs would be, nominal. 
6. Estimate prepared by : Martha Jane Coury. 
7. Estimate approved by : 
C. G. Ntjckols 
(For James L. Blum, 
Assistant Director for Budget Analysis.) 
VII. Regulatory Impact Statement 
The Committee is aware of its responsibility to make a determina- 
tion pursuant to Section 602 of Senate Resolution 4 of the regulatory 
impact of legislation. Though the actual number of facilities, labora- 
tories. and individuals involved with recombinant DNA activities is 
unavailable, the Committee estimates that approximately 340 labora- 
tories, in 85 facilities involving 1,700 scientists and technicians, would 
be affected by the regulations to be promulgated pursuant to this bill. 
With particular regard to Section 1817 of this bill which addresses 
‘"disclosure of data,” the Committee determines that the regulations 
to be promulgated pursuant to this bill would not have an undue effect 
on personal privacy. While the regulations to be promulgated pursuant 
S. Rep. 359—77 3 
[ 757 ] 
